Roman Butler Fullerton & Co Buys Mastercard Inc, SPDR Dow Jones Industrial Average, iShares Preferred and Income Securities ETF, Sells Novartis AG, iShares Russell 1000 Growth, BioTelemetry Inc

Investment company Roman Butler Fullerton & Co buys Mastercard Inc, SPDR Dow Jones Industrial Average, iShares Preferred and Income Securities ETF, Vanguard Div Appreciation, iShares MSCI China ETF, SS&C Technologies Holdings Inc, NVIDIA Corp, Ulta Beauty Inc, Vanguard Growth, Pfizer Inc, CyberArk Software, Euronet Worldwide Inc, Iron Mountain Inc, Essent Group, Globant SA, Honeywell International Inc, Merck Inc, NMI Holdings Inc, Dell Technologies Inc, Invesco S&P 500 Low Volatility, Intel Corp, iShares Morningstar Large-Cap Growth, Alexion Pharmaceuticals Inc, Invesco QQQ Trust Series 1, Walgreens Boots Alliance Inc, Facebook Inc, American Tower Corp, US Bancorp, Cisco Systems Inc, Stryker Corp, Linde PLC, Citigroup Inc, Ladenburg Thalmann Financial Services Inc, Hawaiian Holdings Inc, iShares Edge MSCI Min Vol USA, Capital One Financial Corp, Vanguard FTSE All World Ex US, Shopify Inc, Enbridge Inc, Vanguard Real Estate, Spire Inc, Consolidated Edison Inc, Kinder Morgan Inc, Centene Corp, Amgen Inc, Eli Lilly and Co, Emerson Electric Co, Royal Bank of Canada, 3M Co, iShares U.S. Technology, sells Novartis AG, iShares Russell 1000 Growth, BioTelemetry Inc, AmeriGas Partners LP, CME Group Inc, Qualcomm Inc, Vertex Pharmaceuticals Inc, Regeneron Pharmaceuticals Inc, UnitedHealth Group Inc, Burlington Stores Inc, iShares Core Moderate Allocation, Boeing Co, iShares U.S. Health Care Providers, Caterpillar Inc, Abiomed Inc, Spotify Technology SA, Zoetis Inc, SPDR Select Sector Fund - Health Care, Liberty All Star Equity Fund, Coherus BioSciences Inc, Broadcom Inc, PIMCO High Income Fund, Ubiquiti Networks Inc, Western Asset Municipal High Income Fund Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Roman Butler Fullerton & Co. As of 2019Q1, Roman Butler Fullerton & Co owns 168 stocks with a total value of $139 million. These are the details of the buys and sells.

For the details of ROMAN BUTLER FULLERTON & CO's stock buys and sells, go to https://www.gurufocus.com/guru/roman+butler+fullerton+%26+co/current-portfolio/portfolio

These are the top 5 holdings of ROMAN BUTLER FULLERTON & CO
  1. SPDR Dow Jones Industrial Average (DIA) - 17,065 shares, 3.17% of the total portfolio. Shares added by 370.24%
  2. iShares S&P 500 Growth (IVW) - 25,087 shares, 3.10% of the total portfolio. Shares reduced by 16.64%
  3. Apple Inc (AAPL) - 22,038 shares, 3.00% of the total portfolio. Shares added by 16.06%
  4. Mastercard Inc (MA) - 16,986 shares, 2.87% of the total portfolio. New Position
  5. AT&T Inc (T) - 111,603 shares, 2.51% of the total portfolio. Shares added by 5.15%
New Purchase: Mastercard Inc (MA)

Roman Butler Fullerton & Co initiated holding in Mastercard Inc. The purchase prices were between $181.18 and $235.87, with an estimated average price of $214.63. The stock is now traded at around $244.41. The impact to a portfolio due to this purchase was 2.87%. The holding were 16,986 shares as of .

New Purchase: iShares MSCI China ETF (MCHI)

Roman Butler Fullerton & Co initiated holding in iShares MSCI China ETF. The purchase prices were between $51 and $62.87, with an estimated average price of $58.88. The stock is now traded at around $63.62. The impact to a portfolio due to this purchase was 0.49%. The holding were 10,947 shares as of .

New Purchase: SS&C Technologies Holdings Inc (SSNC)

Roman Butler Fullerton & Co initiated holding in SS&C Technologies Holdings Inc. The purchase prices were between $43.37 and $63.69, with an estimated average price of $55.41. The stock is now traded at around $66.20. The impact to a portfolio due to this purchase was 0.48%. The holding were 10,583 shares as of .

New Purchase: NVIDIA Corp (NVDA)

Roman Butler Fullerton & Co initiated holding in NVIDIA Corp. The purchase prices were between $127.99 and $183.94, with an estimated average price of $154.95. The stock is now traded at around $191.02. The impact to a portfolio due to this purchase was 0.42%. The holding were 3,239 shares as of .

New Purchase: Ulta Beauty Inc (ULTA)

Roman Butler Fullerton & Co initiated holding in Ulta Beauty Inc. The purchase prices were between $243.36 and $348.73, with an estimated average price of $301.41. The stock is now traded at around $354.00. The impact to a portfolio due to this purchase was 0.42%. The holding were 1,699 shares as of .

New Purchase: Vanguard Growth (VUG)

Roman Butler Fullerton & Co initiated holding in Vanguard Growth. The purchase prices were between $130.18 and $158.27, with an estimated average price of $147.84. The stock is now traded at around $163.24. The impact to a portfolio due to this purchase was 0.4%. The holding were 3,554 shares as of .

Added: SPDR Dow Jones Industrial Average (DIA)

Roman Butler Fullerton & Co added to a holding in SPDR Dow Jones Industrial Average by 370.24%. The purchase prices were between $226.72 and $260.89, with an estimated average price of $251.26. The stock is now traded at around $266.05. The impact to a portfolio due to this purchase was 2.5%. The holding were 17,065 shares as of .

Added: iShares Preferred and Income Securities ETF (PFF)

Roman Butler Fullerton & Co added to a holding in iShares Preferred and Income Securities ETF by 69.96%. The purchase prices were between $34.23 and $36.63, with an estimated average price of $35.9. The stock is now traded at around $36.64. The impact to a portfolio due to this purchase was 0.76%. The holding were 70,445 shares as of .

Added: Vanguard Div Appreciation (VIG)

Roman Butler Fullerton & Co added to a holding in Vanguard Div Appreciation by 254.27%. The purchase prices were between $95.15 and $109.87, with an estimated average price of $105.3. The stock is now traded at around $112.93. The impact to a portfolio due to this purchase was 0.57%. The holding were 10,040 shares as of .

Added: Pfizer Inc (PFE)

Roman Butler Fullerton & Co added to a holding in Pfizer Inc by 27.27%. The purchase prices were between $39.53 and $43.65, with an estimated average price of $42.24. The stock is now traded at around $39.44. The impact to a portfolio due to this purchase was 0.39%. The holding were 59,958 shares as of .

Added: Iron Mountain Inc (IRM)

Roman Butler Fullerton & Co added to a holding in Iron Mountain Inc by 209.19%. The purchase prices were between $32.1 and $37.2, with an estimated average price of $35.28. The stock is now traded at around $35.90. The impact to a portfolio due to this purchase was 0.37%. The holding were 21,801 shares as of .

Added: Merck & Co Inc (MRK)

Roman Butler Fullerton & Co added to a holding in Merck & Co Inc by 34.20%. The purchase prices were between $72.92 and $83.17, with an estimated average price of $78.33. The stock is now traded at around $74.78. The impact to a portfolio due to this purchase was 0.28%. The holding were 18,434 shares as of .

Sold Out: Novartis AG (NVS)

Roman Butler Fullerton & Co sold out a holding in Novartis AG. The sale prices were between $73.8 and $84.4, with an estimated average price of $78.6.

Sold Out: BioTelemetry Inc (BEAT)

Roman Butler Fullerton & Co sold out a holding in BioTelemetry Inc. The sale prices were between $55.35 and $77.59, with an estimated average price of $68.68.

Sold Out: AmeriGas Partners LP (APU)

Roman Butler Fullerton & Co sold out a holding in AmeriGas Partners LP. The sale prices were between $24.43 and $31.46, with an estimated average price of $29.2.

Sold Out: CME Group Inc (CME)

Roman Butler Fullerton & Co sold out a holding in CME Group Inc. The sale prices were between $162.58 and $188.12, with an estimated average price of $177.05.

Sold Out: Qualcomm Inc (QCOM)

Roman Butler Fullerton & Co sold out a holding in Qualcomm Inc. The sale prices were between $49.4 and $58, with an estimated average price of $54.01.

Sold Out: Vertex Pharmaceuticals Inc (VRTX)

Roman Butler Fullerton & Co sold out a holding in Vertex Pharmaceuticals Inc. The sale prices were between $163.73 and $194.7, with an estimated average price of $184.61.



Here is the complete portfolio of ROMAN BUTLER FULLERTON & CO. Also check out:

1. ROMAN BUTLER FULLERTON & CO's Undervalued Stocks
2. ROMAN BUTLER FULLERTON & CO's Top Growth Companies, and
3. ROMAN BUTLER FULLERTON & CO's High Yield stocks
4. Stocks that ROMAN BUTLER FULLERTON & CO keeps buying